Evidence map›Paper›PMID 42452900›Full record

ArticleAdvanced healthcare materials2026

Defect-Engineered Porous C

Longwei Wang, Min An, Yahui Wang, Weilin Zhong, Lihan Cai, Jian Zhang, Jianfang Li, Jianmin Xiao, Guilong Zhang, Longhua Ding and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Longwei WangSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Min AnSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Yahui WangSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Weilin ZhongSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Lihan CaiInstitute for Advanced Interdisciplinary Research, School of Chemistry and Chemical Engineering, University of Jinan, Jinan, P. R. China.
Jian ZhangDivision of Systems and Synthetic Biology, Department of Life Sciences, Chalmers University of Technology, Göteborg, Sweden.
Jianfang LiSchool of Chemistry and Chemical Engineering, Shanxi University, Taiyuan, P. R. China.
Jianmin XiaoSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Guilong ZhangSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Longhua DingInstitute for Advanced Interdisciplinary Research, School of Chemistry and Chemical Engineering, University of Jinan, Jinan, P. R. China.ORCID https://orcid.org/0000-0001-7167-0771
Geng TianSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.
Aizhu WangInstitute for Advanced Interdisciplinary Research, School of Chemistry and Chemical Engineering, University of Jinan, Jinan, P. R. China.
Xin YuSchool of Pharmacy, Shandong Medical And Pharmaceutical University, Yantai, P. R. China.ORCID https://orcid.org/0000-0003-0543-5567

Funding

National Natural Science Foundation of China 52272212National Natural Science Foundation of China 52422213National Natural Science Foundation of China 52502336Natural Science Foundation of Beijing 2254100Natural Science Foundation of Shandong Province ZR2022JQ20Natural Science Foundation of Shandong Province ZR2024MA030Natural Science Foundation of Shandong Province ZR2025QC471Natural Science Foundation of Yantai 2025YT06000840Taishan Scholar Project of Shandong Province tsqn202211168Taishan Scholar Project of Shandong Province tsqn202312247
6 · The paper itself

Abstract

Bacterial infections and the spread of multidrug-resistant pathogens pose a growing threat to public health as conventional antibiotics lose efficacy, necessitating efficient non-antibiotic antibacterial strategies. Although ROS-based photocatalysis and nanozyme catalysis are promising, single-component systems are often limited by charge-carrier recombination, low ROS generation efficiency, and slow reaction kinetics. Herein, we report a porous C

Indexed as

Anti-Bacterial AgentsNitrogen CompoundsQuantum DotsAnimalsBiofilmsCatalysisMiceNitrilesPorosityReactive Oxygen SpeciesAnti-Bacterial AgentscyanogenNitrilesNitrogen CompoundsReactive Oxygen Speciesantibacterial activitymultidrug‐resistant pathogensnanozymephotocatalysisskin anti‐infective therapy

Identifiers

PMID42452900
PMCPMC13474107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.